Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TissueGene Inc.
DescriptionAllogeneic human chondrocytes modified to produce bone morphogenetic protein 2 (BMP-2)
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPreclinical
Standard IndicationBone repair
Indication DetailsTreat bone regeneration; Treat fractures and joint fusions
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today